PEG-MGF (Pegylated Mechano Growth Factor) is a modified form of Mechano Growth Factor (MGF), which is itself an alternatively spliced isoform of the IGF-1 gene expressed in response to mechanical strain and muscle damage. The native MGF has a unique E-domain peptide that differs from systemic IGF-1 and is thought to act locally at the site of muscle injury to activate satellite cells. PEGylation – the covalent attachment of polyethylene glycol chains – dramatically extends MGF’s half-life from minutes to several days.
Researchers have studied PEG-MGF for its potential role in muscle satellite cell activation and proliferation. In vitro studies have examined whether the MGF E-domain peptide can stimulate quiescent satellite cells to enter the cell cycle, a critical early step in muscle repair and hypertrophy. Research has explored how PEGylation affects the peptide’s tissue distribution, receptor binding kinetics, and biological activity compared to unmodified MGF.
Preclinical animal studies have examined PEG-MGF’s effects on muscle mass and recovery following induced injury or atrophy. Research has explored its interaction with the IGF-1 receptor and the potential existence of a distinct MGF receptor. Studies have also examined its potential neuroprotective properties, as MGF expression has been observed in neural tissues following injury.
For research use only. Not for human consumption. Iron Prairie Labs products are intended for qualified researchers and laboratory use only.
